$TTNP
Came alive again on Friday.
Larger float but big volume could compensate that.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares surged 4.5% to $0.18. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
